Current Trends in Diagnostics Research
Diagnostics research continues to move toward faster, more accessible testing. Point-of-care platforms are increasingly able to deliver molecular-grade results outside of centralised laboratories, shortening the time between sample collection and clinical decision-making.
Multiplexing, the ability to detect multiple targets in a single reaction, is also a significant area of development, allowing laboratories to screen for several pathogens or markers simultaneously rather than running separate tests.
Alongside these platform advances, there is growing emphasis on robust validation and quality management, particularly as diagnostic products move between research use and clinical or regulated use. Euro Diagnostics Limited's R&D and validation services support partners navigating this transition.